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Abstract
The aim of this study was to develop a new breast density classification system for dedicated breast computed tomography (BCT)
based on lesion detectability analogous to the ACR BI-RADS breast density scale for mammography, and to evaluate its interrater
reliability.
In this retrospective study, 1454 BCT examinations without contrast media were screened for suitability. Excluding datasets
without additional ultrasound and exams without any detected lesions resulted in 114 BCT examinations. Based on lesion
detectability, an atlas-based BCT density (BCTD) classification system of breast parenchyma was defined using 4 categories.
Interrater reliability was examined in 40 BCT datasets between 3 experienced radiologists.
Among the included lesions were 63 cysts (55%), 18 fibroadenomas (16%), 7 lesions of fatty necrosis (6%), and 6 breast cancers
(5%) with a median diameter of 11mm. X-ray absorption was identical between lesions and breast tissue; therefore, the lack of fatty
septae was identified as the most important criteria for the presence of lesions in glandular tissue. Applying a lesion diameter of 10
mm as desired cut-off for the recommendation of an additional ultrasound, an atlas of 4 BCTD categories was defined resulting in a
distribution of 17.5% for density A, 39.5% (B), 31.6% (C), and 11.4% (D) with an intraclass correlation coefficient (ICC) among 3
readers of 0.85 to 0.87.
We propose a dedicated atlas-based BCTD classification system, which is calibrated to lesion detectability. The new classification
system exhibits a high interrater reliability and may be used for the decision whether additional ultrasound is recommended.
Abbreviations: BCT = breast computed tomography, BCTD = breast computed tomography density, ICC = Intraclass
correlation coefficient, MD = mammographic density.
Keywords: breast density, interrater reliability, spiral breast-CT
Key Points
 Presentation of image examples for the estimation of
breast density in dedicated breast computed tomography.
1. Introduction
Breast cancer is themost commoncancerdiagnosed inwomenwith
an incidence of 12.3% in the normal populationwith amedian age
at diagnosis of 61years and a increasing trend (incidence of 9.09%
in the 1970s).[1] Mammography screening is known to reduce
mortality in breast cancer, and it has been estimated that the
combinationof amammographyscreeningprogramwith adjuvant
therapy results in a relative reduction inmortality of 37%.[2]Apart
from genetic disposition, hormonal influences such as estrogen
replacement therapy and oral contraception are discussed as
potential risk factors. Moreover, mammographic density (MD)
was demonstrated as an important risk factor for the development
of breast cancer.[3] Women with extremely dense breast tissue
demonstrate a 2- to 6-fold increase of breast cancer risk.[4]
MD is defined as the relative amount of glandular tissue based
on the mammographic appearance of fibroglandular tissue,
which is not inferable from physical examination.[5] In MD also
changes in breast density due to different hormonal levels as
menopausal transition and aging are reflected. A standardized
reporting system for MD was introduced according to the ACR
BI-RADS (American College of Radiology Breast Imaging-
Reporting and Data System) catalogue last updated in 2013,
classifyingMD in 4 categories from “A” to “D,”with category A
denoting almost completely fatty tissue, B denoting scattered
fibroglandular tissue, C indicating heterogeneously dense tissue
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and D representing extremely dense tissue.[6] Overall, 40% of
women have MD of ACR BI-RADS C or D, in women below 50
years dense MD is found in more than half of the patients.[7]
Apart from its meaning for the estimation of breast cancer risk,
MD is important for the assessment of the diagnostic perfor-
mance of mammography screening. For low MD, a sensitivity of
mammography for the detection of breast cancer of 87% to 98%
is reported, which substantially drops to 30% to 63% in
extremely dense breasts.[8–11] In patients with mammographic
dense breasts, supplemental ultrasound may increase the
detection rate for breast cancer,[8,12] which is reflected in many
guidelines recommending additional ultrasound in ACR BI-
RADS densities “C” and “D.”[13]
Recently, cone-beam and spiral breast-CT using photon-
counting detector technology has been introduced as a new truly
3D breast imaging technology.[14] The advantages of breast-CT
(BCT) over mammography are the increased patient comfort (no
breast compression needed),[15] the possibility of multiplanar
reconstructions with a high isotropic spatial resolution, and the
lack of super-imposing glandular tissue[16] at comparable
radiation dose to screening mammographies in spiral BCT.[17]
Cone-beam breast-CT is reported to have a significant higher
dose than mammography.[18,19] The sensitivity of BCT in dense
MD was reported to be higher compared to 2D mammogra-
phy.[19,20] The high isotropic spatial resolution allows 3
dimensional analysis and density measures of detected lesions
and contrast-enhanced BCT might be an alternative modality for
patients with contraindications to MR mammography.[21–23]
The existing studies on BCT regarding lesion detectability and
BCTD use the ACR BI-RADS atlas to describe MD in
BCT.[19,20,24] This existing atlas has been developed for
mammography and does not take into consideration the true
3D nature of the images in BCT. The lack of superposition of
breast tissue in BCT might have an influence on the perceived
density. In this study, we analyzed BCTD in correlation to lesion
detectability, created a dedicated atlas-based 4-level density scale
for the use in BCT analogous to the ACR BI-RADS density for
mammography, and evaluated the proposed scale regarding
interrater reliability. The main motivation was to allow an
estimation of the sensitivity of each individual BCT study for
future use and to help radiologists take a decision whether
additional ultrasound is necessary in asymptomatic patients.
2. Materials and method
2.1. Patient selection
A retrospective analysis of patient data in our local radiologic
information system was performed, which was approved by the
local ethics committee. Informed consent was waived for this
retrospective study. All the BCT examinations at our institution
performed between August 2018 andOctober 2019were selected
independently of the indication for imaging (727 exams
consisting of 2 sides, therefore 1454 breast exams). Only exams
with additional ultrasound on the same day were further
evaluated (N=523) and the radiologic report analyzed regarding
presence of any described lesion. Exams without lesions or very
small lesions (<=6 mm) were excluded (N=409). A total of 114
BCT examinations were finally evaluated. Mean age of this final
patient cohort was 54years (36–80years) with median age of 52
years. Additional demographic data is not routinely documented
in the radiologic report or in our picture archiving and
communication system and was therefore not further analyzed.
In the picture archiving and communication system archive,
mammographies of the same patients were searched up to the
year 2010 and if available MD was compared to BCTD.
2.2. BCT examinations
All patient examinationswere performed on a dedicated breast CT
imager using spiral image acquisition with a CdTe photon-
counting detectorwith a detector pixel size of (0.1mm)2 and a total
detector areaof28050mm2 (nu-view,AB-CTGmbH,Erlangen,
Germany). The maximum diameter of the Field-of-View is 190
mm, and the scan length can be adjusted to the values 80, 120, and
160mm depending of the length of the breast. The x-ray tube
exhibits a 0.3mm focal spot size, and 3-mmAl filtration is applied.
A fixed X-ray tube voltage of 60kV is used, whereas the tube
currentmay be adjusted between 5mAand 125mA. In all patients,
a tube current of 32mAwas applied. No contrast media was used.
The examination scans were acquired in a spiral mode with 2
seconds rotation time, 2000projections per rotation, except for the
first rotation. Image reconstruction was done in standard mode
with a soft kernel (Shepp-Logan) at (300mm)3 voxel sizewith 22
detector binning using a Feldkamp-type filtered back projection
(FBP) algorithm. Breast ultrasound was either performed with
handheld ultrasound by a radiologic resident (2 different vendors:
GE Logic E9 (N=20 patients) or Philips iU22 (N=59 patients)
with a linear transducer with at least 11MHz) or with automated
breast ultrasound (Invenia Automated Breast Ultrasound System,
General Electric Healthcare, Sunnyvale, CA) using a C 15-6XW
reverse curve, 5–14 MHz transducer with an aperture length of
15.3cm, a transducer travel distance of 16.9cm, and a depth up to
5cm (N=35 patients).
2.3. Breast density
Based on the lesion detectability, the BCT examinations were
divided in 4 categories with different Breast-CT Density (BCTD):
1. almost no glandular tissue with complete visibility of all the
lesions,
2. some glandular tissue with soft tissue lesions larger than 10
mm visible,
3. partially dense breast tissue with lesions of 10mm potentially
not visible,
4. extremely dense tissue with severely limited visibility of
lesions.
The goal was to be able to detect 10/10 lesions in density A, at
least 8/10 in density B and below 5/10 in density C and D to
reflect the high sensitivity of mammography for low BCTD and
decreased detection rate in high BCTD. From the categorization,
the most typical examples were determined as an atlas guide with
2 different views:AG1, coronary plane, raw images from the BCT
(0.3mm slice thickness), and AG2, axial images, multiplane
reformatted images (3mm slice thickness averaged, mpr).t
2.4. Interrater reliability
The proposed atlas guide was evaluated regarding interrater
reliability by selecting 40 example BCT examinations regardless
of the presence of lesions with different levels of BCTD. These
exemplary BCT studies were selected by the main author solely
based on their perceived density. Three radiologists, all with
extensive experience in the assessment of BCT examinations,
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were asked to categorize these 40 cases regarding BCTD using the
proposed atlas guide. Each reader evaluated each exam:
1. using AG1 (raw images, coronal plane), and
2. using AG2 (mpr, axial plane).
The intraclass correlation coefficient (ICC) between the 3
readers using 4 discrete categories and Cohen kappa between
every pair of readers using only 2 categories (A/B vs C/D) were
calculated using SPSS (IBM SPSS Statistics version 25). According
to Kundel and Polansky and Landis and Koch, an ICC greater
than 0.80 was considered to be indicative of “almost perfect
agreement (ICC=1, “perfect agreement”).[25,26] To assess
differences in the median of the classification results of the
cohort among the 3 readers, the rank-based non-parametric
Kruskal–Wallis H test for comparison of 3 groups has been
applied to both readings AG1 and AG2 as well as to the decision
whether additional ultrasound is required (density A/B vs C/D in
AG1 and AG2) with a significance level of 0.05.
3. Results
3.1. Lesion characteristics
One hundred fourteen lesions were included: 63 cysts (55%), 18
fibroadenomas (16%), 7 lesions of fatty necrosis (6%), 6 breast
cancers (5%), 14 undetermined lesions with benign sonographic
features (12%), and 6 various soft tissue lesions (5%). Mean size
of the lesions was 13mm (7–39mm) with amedian size of 11mm.
Overall 40 lesions were below 10mm, 50 lesions were between
10 to 15mm and 24 lesions were larger than 15mm.
3.2. Establishment of a BCTD atlas
Overall 79 of 114 lesions were detectable in BCT (69% of all
lesions). Typical examples of lesions are provided in Figures 1
and 2. In low BCTD the lesions were easily detectable whereas in
high BCTD lesions were often obscured by surrounding dense
breast tissue. There was no relevant density contrast neither
between glandular tissue and breast lesions, nor among different
types of breast lesions. However even in relatively dense breast
tissue the presence of small septae of fatty tissue between the
fibroglandular structures enabled an exclusion of lesions larger
than 10mm because both, soft tissue lesions and cystic lesions
lack the presence of fatty septae within their structures. This
feature was used as the main criterion to distinguish BCTD
categories B (presence of fatty septae between fibroglandular
tissue even in the densest areas of the breast) and C (absence of
fatty septae between fibroglandular tissue in dense spots of
glandular tissue larger than 10mm). Besides lesion visibility the
most dense part of the breast tissue was evaluated, as in the ACR
Figure 1. BCT slices axial (A), coronal (B) and sagittal (C) plane and corresponding ultrasound (D). Cystic lesion (arrow, 17mm) visible even in relatively dense BCTD
due to fatty septae. Note the second, smaller lesion in a (arrowhead, 14mm).
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BI-RADS catalogue regarding MD. Two atlas guides with image
examples of 4 levels of BCTD were created based on the above
described features, giving 2 examples for every density level in 2
different planes. Atlas guide AG1 is provided in Figure 3 with
coronary raw images of standard BCT images with 0.3mm slice
thickness, and atlas guide AG2 is demonstrated in Figure 4 with
multiplane reformatted images of 3mm slice thickness.
3.3. Breast density distribution and lesion detectability
Applying the 2 BCTD guides AG1 and AG2, the following
distribution of breast densities was present in the cohort of 114
patient examinations: 20 (17.5%) were estimated as density A,
45 (39.5%) as density B, 36 (31.6%) as density C and 13 (11.4%)
as density D. Overall in 31 patients a previous mammography
was available. In 13 patients (42%) MD was the same as the
BCTD and in 18 patients (52%) MD was 1 class higher as
evaluated with BCT. In patients below 50years (N=43) there
were 1 density A, 13 density B, 20 density C and 9 density D. In
patients above 60years (N=26) there were 10 density A, 13
density B, 2 density C and 1 density D. Patients between 50 and
60years (N=45) showed mostly density B and D (Table 1). With
these proposed categories of different BCTD 20/20 lesions
(100%) in density A, 38/45 lesions (84%) in density B, 15/36
Figure 2. BCT slices axial (A), coronal (B) and sagittal (C) plane and
corresponding ultrasound (D). Sonographic proven cyst (12mm) not visible in
BCT in a patient with very high BCTD without fatty septae in the densest
parenchymal areas.
Figure 3. Atlas guide 1 (AG1), coronal plane, raw images with 0.3mm slice thickness. Breast density classification from low density (A) to high density (D) with 2
examples for each category.
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lesions (42%) in density C and 6/13 lesions (46%) in density D
were detectable reflecting the high sensitivity of BCT for lesion
detection in low BCTD and the decreased sensitivity for higher
BCTD. These results are in accordance to the previously stated
sensitivities of BCT.[18–20]
3.4. Interrater reliability
Three experienced radiologists (JW 2years of experience in breast
imaging, NB 7years, and AB 15years) evaluated the 40 BCT
examinations using the proposed atlas guides AG1 and AG2with
results shown in Table 2. Intraclass correlation coefficient was
0.87 (95% CI 0.79, 0.92) for AG1 (raw images, coronal plane)
and 0.85 (95% CI 0.77, 0.91) for AG2 (mpr, axial plane),
reflecting the near perfect interrater correlation.
Figure 4. Atlas guide 2 (AG2), axial plane, multiplane reformatted images with 3mm averaged slice thickness. Breast density classification from low density (A) to
high density (D) with 2 examples for each category.
Table 1
Distribution of breast-CT density (BCTD) of the analyzed cohort
regarding patient age.
A B C D Total
<50 yr 1 13 20 9 43
50–60 yr 9 19 14 3 45
>60 yr 10 13 2 1 26
Total 20 45 36 13 114
Table 2
Estimation of breast-CT density (BCTD) of different readers using
AG1 and AG2 with 40 examplary breast-CT (BCT) exams.
Reader 1 Reader 2 Reader 3
AG1 AG2 AG1 AG2 AG1 AG2
A 9 9 9 9 18 14
B 12 11 13 13 9 4
C 11 12 13 13 7 10
D 8 8 5 5 6 12
Table 3
Binary evaluation of breast-CT density (low vs high BCTD) by the
different readers using AG1 and AG2 with 40 exemplary breast-CT
(BCT) exams.
Reader 1 Reader 2 Reader 3
AG1 AG2 AG1 AG2 AG1 AG2
Low 21 20 22 22 27 18
High 19 20 18 18 13 22
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The results for the binary evaluation (A/B vs C/D) are shown in
Table 3. The kappa-values between the readers using only 2
categories (A/B vs C/D) are demonstrated in Table 4.
Comparing the 2 atlas guides the results were similar.
Subjective evaluation of the presence of fatty septae was reported
to be easier in AG1. Reader 3 evaluated the BCTD systematically
higher in AG2 as compared to AG1. The use of AG1 was faster
and easier because there was no need for post-processing
procedures.
In none of the statistical test, a difference in the median of the
groups could be identified with all calculated P values above the
significance level of .05: AG1 with P= .16 (H=3.65), AG 2 with
P= .81 (H=0.407), AG1(A/B vs C/D) with P= .46 (H=1.53),
and AG2(A/B vs C/D) with P= .74 (H=0.60).
4. Discussion
In this study, we propose a breast density classification for breast
CT examinations based on lesion detectability with fatty septae
between glandular tissue being identified as the most important
criterion for visibility of potential lesions. Two different atlas
guides were evaluated, AG1 based on the raw images of BCT
without further postprocessing, and AG2 with axial reformation
and averaging of 10 slices; thereby resembling the familiar ACR
BIRADS mammography breast density atlas. We were able to
demonstrate that both proposed atlas guides exhibit a high
reliability with excellent interrater agreement. We identified AG1
as the most suitable atlas guide from the 2 evaluated schemes,
mainly because of the advantage that no further postprocessing is
required and classification can be carried out directly from the
raw images.
BCT is a new and promising modality in breast imaging. The
advantages are the high isotropic resolution and patient comfort
since there is no need for breast compression. Thirty five perceny
of women experience discomfort and up to 6% frank pain during
and following mammography[27] and up to 46% of women who
do not attend further mammography do so because of pain in
their first examination.[28,29] BCT is the only modality that can
detect suspicious microcalcifications and soft tissue breast
cancers without patient discomfort. Our scanner is the first
clinically approved spiral BCT with a single photon-counting
detector. In contrast with cone-beam BCT the radiation dose is
lower and similar to mammography.[19,30] Even if the sensitivity
of BCT is reported to be higher than sensitivity of mammography
in women with high MD, missed breast cancers due to
superimposed breast tissue is an issue as in mammography.[19]
Therefore, a reporting system for BCTD in BCT as a surrogate for
the sensitivity of the examination analogous to the ACR BI-
RADS 4-level density scale is needed.
MD density has 2 important aspects:
1. MD is an important risk factor for the development of breast
cancer with higher MD leading to higher breast cancer risk,
2. MD influences the sensitivity of mammography for the
detection of breast cancer with higher MD resulting in lower
sensitivity.
For MD, both aspects are not identically correlated to the
classification system. Aspect
1. is mostly linked to the amount of glandular tissue, whereas
aspect
2. is related to the amount and distribution of glandular tissue.
The differences have been exposed at the most recent revision
of the ACR BIRADS density classification. Before 2013, the
amount of glandular tissue in percent in the mammography has
been used for the classification ofMD. It has been recognized that
this form of classification is too rigid for the decision whether
additional ultrasound is recommended or not. In the ACR BI-
RADS atlas after 2013, the classification has been recalibrated
reflecting the unsuitability of quantitative techniques describing
now the MD in a Likert scale with example images. Similarly, a
new density classification system is required for spiral BCT due to
the higher lesion detectability. The most important aspect here is
the consideration of fatty septae between glandular tissue, which
is not applicable in mammography due to its nature as a
projection technique.
For the establishment of the BCTD classification, the decisions
for categories A (even very small lesions can be detected due to the
lack of glandular tissue) and D (even large lesions can be missed
due to the extremely dense glandular tissue) are relatively straight
forward. The main calibration of the classification has to be
carried out for the distinction of categories B (glandular tissue
present but no ultrasound necessary) and C (glandular tissue
present requiring supplemental ultrasound). For this reason, we
evaluated all available BCT datasets at our institution for lesion
detectability within glandular tissue. During the evaluation of
lesion visibility and breast density, we noticed that in some
patients even with high BCTD the presence of fatty septae
between the fibroglandular tissue enabled us to exclude larger
lesions. This feature was used to differentiate between BCTD
categories B and C using a threshold of 10mm as the desired cut-
off meaning that in BCTD category B a soft tissue lesion of at least
10mm should be detectable without additional ultrasound
examination. From our findings, we extracted example images
and the resulting atlas guide AG1, which we propose, is presented
in Figure 3. The distribution of BCTD in the 4 categories in the
114 BCT exams were similar to the reported distribution of MD
in mammography.[7]
Comparing the BCTD to mammographies in those patients,
in which a previous mammography had been carried out, a
decrease in the density scale was seen in the large majority of
cases. This decrease of density may in part be explained because
of interval involution of breast tissue. However, Ma et al
showed a trend towards higher density classification in cone-
beam breast-CT compared to mammography.[24] As we
observed a decrease in the BCTD scale, it may be hypothesized
that this finding is potentially due to the increased reader-
Table 4
Kappa-values between each pair of readers using only 2
categories of breast-CT density (low vs high BCTD) for each AG
separately. According Landis and Koch 0.6 to 0.8 substantial and
>0.8 almost perfect agreement.
AG1 Reader 1 Reader 2 Reader 3
Reader 1 0.85 0.70
Reader 2 0.74
Reader 3
AG2 Reader 1 Reader 2 Reader 3
Reader 1 0.80 0.9
Reader 2 0.80
Reader 3
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perceived sensitivity of BCT compared to mammography and
the respective lower classification in the density scale.
Interestingly density distribution varied with patient age which
is known in mammography[7] and can be viewed as a quality
criterion for the evaluation of BCTD.
In mammography, MD is rated based on a visual scale
according to the ACR BI-RADS catalogue, which gives the
radiologists some freedom in the decision whether the density and
distribution of glandular tissue in the mammography require
additional ultrasound. However, such an objective decision
making comes at the short-coming of substantial inter-reader and
even intra-reader variability.[31,32] The standardization of such a
decision using machine learning seem straight forward, and
particularly deep convolutional neural networks have been
successfully applied to classify MD according to the BI-RADS
catalogue.[33] In breast-CT a machine learning approach for
classification of BCTD seems also highly desirable though more
complicated to achieve due to the large size of the 3-dimensional
BCT datasets.
This retrospective study has several limitations: First, a
relatively small number of examinations were used to calculate
the interrater reliability. A larger cohort might be necessary to
confirm the high values of ICC and Kappa using the proposed
atlas guide. Second, no analysis regarding different lesion types
was performed. Therefore, it remains unclear whether a better
atlas guide could be proposed calibrated to the detection of breast
cancer alone. Third, no prospective study was carried out, and it
remains unclear how the initial decision on supplemental
ultrasound without the establishment of an atlas guide for
standardization might have influenced the study cohort. Fourth,
no correlation of BCTD to mammographic breast density or
quantitative breast density assessment was done, which was out
of the scope of this study. Fifthly, our study does not evaluate the
sensitivity or specificity of breast cancer detection in BCT
regarding different levels of BCTD.
5. Conclusion
Lesion detection in X-ray based breast imaging is challenging in
women with dense MD, which is reflected in guidelines
recommending supplemental ultrasound for high MD. Spiral
BCT is an interesting new modality not requiring painful breast
compression and potentially exhibiting higher sensitivity com-
pared to mammography. A new dedicated BCTD classification
system is needed providing a standardization for the decision
whether supplemental ultrasound should be performed in
conjunction with BCT and to give the referring physician an
estimate of the sensitivity of BCT in women with dense breasts.
We analyzed 114 BCT exams over a period of 15months
regarding lesion visibility and created a 4-point atlas-based
BCTD classification, analogous to the ACR BI-RADS scale for
mammography, for future use in BCT. With this classification
90% of the sonographically known lesions were detectable in
BCT in low BCTD (A and B) whereas only 43% of lesions were
visible in high BCTD (C and D) in our cohort, thus justifying
additional ultrasound in high BCTD. The new BCTD classifica-
tion is easy to use and exhibits high interrater reliability with an
intraclass correlation coefficient of over 0.85. This atlas is
thought for human readers allowing a visual estimation of BCTD,
future research might be done regarding machine learning
algorithms and (semi-)quantitative automated analysis of BCTD
in spiral BCT.
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